Tempus AI, Inc. (TEM)

Market Cap	10.72B
Revenue (ttm)	640.44M
Net Income (ttm)	-800.71M
Shares Out	157.45M
EPS (ttm)	-8.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,811,650
Open	76.51
Previous Close	76.72
Day's Range	67.74 - 77.00
52-Week Range	22.89 - 91.45
Beta	n/a
Analysts	Buy
Price Target	59.60 (-12.47%)
Earnings Date	Feb 24, 2025

About TEM

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to p...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 14, 2024
• Employees: 1,952
• Stock Exchange: NASDAQ
• Ticker Symbol: TEM
• Website: https://www.tempus.com

Financial Performance

In 2023, Tempus AI's revenue was $531.82 million, an increase of 65.85% compared to the previous year's $320.67 million. Losses were -$265.96 million, -20.35% less than in 2022.

Financial numbers in USD

Analyst Forecast

According to 11 analysts, the average rating for TEM stock is "Buy." The 12-month stock price forecast is $59.6, which is a decrease of -12.47% from the latest price.

Price Target

$59.6

(-12.47% downside)

Analyst Consensus: Buy